Itanagar, June 30: In a remarkable medical achievement, the Tomo Riba Institute of Health and Medical Sciences (TRIHMS) in Arunachal Pradesh has successfully implanted a 3 Tesla MRI-compatible dual chamber automatic implantable cardioverter defibrillator (AICD) in a 37-year-old woman. This groundbreaking procedure, a first in the state, represents a significant advancement in cardiology.
The primary objective of this pioneering intervention was to prevent cardiac arrest by implanting the 3 Tesla MRI-compatible AICD. This state-of-the-art device is specifically designed to monitor and regulate the heart’s rhythm, effectively reducing the risk of life-threatening irregularities. What sets this device apart is its compatibility with 3 Tesla MRI technology, enabling detailed imaging scans without compromising the functionality of the AICD.
The recipient, a 37-year-old woman, was selected for primary prevention of cardiac arrest. The implantable cardioverter-defibrillator provides a crucial line of defense by continuously monitoring the heart’s electrical activity and delivering a life-saving shock if any irregularities or dangerous rhythms are detected. With the dual chamber feature, the device offers enhanced precision and accuracy in responding to cardiac events.
Also Read: Prime Minister Modi Commutes on Delhi Metro for DU Centenary Celebration
The advantages offered by the 3 Tesla MRI-compatible AICD are significant. With its higher magnetic field strength, the device provides improved diagnostic capabilities, facilitating more accurate and detailed imaging. Moreover, its compatibility with MRI machines eliminates the risks associated with traditional devices, which could malfunction or cause harm during scans.
This breakthrough technology opens up new possibilities for patients with AICDs, granting them access to comprehensive diagnostic evaluations without compromising their well-being.
The successful implantation of the 3 Tesla MRI-compatible AICD in Arunachal Pradesh signifies a remarkable advancement in the region’s healthcare infrastructure. It demonstrates TRIHMS’ commitment to delivering state-of-the-art medical treatments and services to its patients.
As news of this achievement spreads, it is expected to inspire and motivate medical professionals and patients in the state, reaffirming the belief that cutting-edge medical advancements can be accessed locally.
The Tomo Riba Institute of Health and Medical Sciences once again establishes itself as a center of excellence in medical research and treatment. Through this pioneering implantation of the 3 Tesla MRI-compatible AICD, TRIHMS sets a new benchmark for healthcare facilities in the region, paving the way for more innovative procedures and advanced care options in the future. This landmark achievement showcases the potential for further advancements in the field of cardiology, ultimately benefiting patients in Arunachal Pradesh and beyond.
